arrow
Return

Ustekinumab

delete2009-05-01
delete30
PRE
AI
K
Kristian Reich *
U
Uma Yasothan
P
Peter J. Kirkpatrick
DOI:10.1038/nrd2878delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY
PLAQUE-TYPE PSORIASIS
QUALITY-OF-LIFE
DOUBLE-BLIND
SKIN
EFFICACY
SAFETY
TRIAL
METAANALYSIS
EXPRESSION
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Nature Reviews Drug Discovery cover
Nature Reviews Drug Discovery
IF:
101.8
Papers:
5.1K
Citations:
5.3W

Organization

D
Dermatologikum Hamburg
Scholars:
184
Papers: 180
Citations: 316
Cited Papers

Cited Papers

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris
err2004-01-05
err851
errOAAI
errLee, E; Trepicchio, WL; Oestreicher, JL; Pittman, D; Wang, F; Chamian, F; Dhodapkar, M; Krueger, JG
errShare
errSave
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis
err2006-10-01
err189
PREAI
errToichi, Eiko; Torres, Gisela; McCormick, Thomas S.; Chang, Timothy; Mascelli, Mary Ann; Kauffman, Catharine L.; Aria, Nancy; Gottlieb, Alice B.; Everitt, Daniel E.; Frederick, Bart; Pendley, Charles E.; Cooper, Kevin D.
errShare
errSave
Medical progress - Psoriasis
err2005-05-05
err1.0K
PREAI
errSchon, MP; Boehncke, WH
errShare
errSave
Expression of interleukin-12 is increased in psoriatic skin
err1998-12-01
err217
errOAAI
errYawalkar, N; Karlen, S; Hunger, R; Brand, CU; Braathen, LR
errShare
errSave
errShare
errSave
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
errLANCET
IF88.5
err2009-02-01
err493
PREAI
errGottlieb, Alice; Menter, Alan; Mendelsohn, Alan; Shen, Yaung-Kaung; Li, Shu; Guzzo, Cynthia; Fretzin, Scott; Kunynetz, Rod; Kavanaugh, Arthur
errShare
errSave
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
errLANCET
IF88.5
err2008-05-01
err1.4K
PREAI
errLeonardi, Craig L.; Kimball, Alexa B.; Papp, Kim A.; Yeilding, Newman; Guzzo, Cynthia; Wang, Yuhua; Li, Shu; Dooley, Lisa T.; Gordon, Kenneth B.
errShare
errSave
researcher View more